Patents by Inventor MADIHA SABIHA DEROUAZI

MADIHA SABIHA DEROUAZI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160031946
    Abstract: The present invention relates to isolated polypeptides comprising: (i) a protein transduction domain consisting of ZEBRA or a fragment thereof that retains the capacity of internalization, (ii) at least one CD4+ epitope; and (iii) at least one CD8+ epitope. It also relates to antigen presenting cells loaded with said polypeptides, and the use thereof in immunotherapy including prevention and/or treatment of cancers or infectious diseases.
    Type: Application
    Filed: October 15, 2015
    Publication date: February 4, 2016
    Inventors: MADIHA SABIHA DEROUAZI, PAUL R. WALKER, PIERRE-YVES DIETRICH
  • Patent number: 9187534
    Abstract: The present invention relates to isolated polypeptides comprising: (i) a protein transduction domain consisting of ZEBRA or a fragment thereof that retains the capacity of internalization, (ii) at least one CD4+ epitope; and (iii) at least one CD8+ epitope. It also relates to antigen presenting cells loaded with said polypeptides, and the use thereof in immunotherapy including prevention and/or treatment of cancers or infectious diseases.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: November 17, 2015
    Assignees: UNIVERSITE DE GENEVE, HOPITAUX UNIVERSITAIRES DE GENEVE
    Inventors: Madiha Sabiha Derouazi, Paul R. Walker, Pierre-Yves Dietrich
  • Publication number: 20120231030
    Abstract: The present invention relates to isolated polypeptides comprising: (i) a protein transduction domain consisting of ZEBRA or a fragment thereof that retains the capacity of internalization, (ii) at least one CD4+ epitope; and (iii) at least one CD8+ epitope. It also relates to antigen presenting cells loaded with said polypeptides, and the use thereof in immunotherapy including prevention and/or treatment of cancers or infectious diseases.
    Type: Application
    Filed: March 9, 2012
    Publication date: September 13, 2012
    Applicants: HOPITAUX UNIVERSITAIRES DE GENEVE, UNIVERSITE DE GENEVE
    Inventors: MADIHA SABIHA DEROUAZI, Paul R. Walker, Pierre-Yves Dietrich